false
Catalog
EP Fellows Curriculum: Current and Future Strategi ...
EP Fellows Curriculum: Current and Future Strategi ...
EP Fellows Curriculum: Current and Future Strategies to Optimize VT Ablation with Imaging
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The speaker discussed the use of imaging in ventricular tachycardia (VT) ablation procedures. He mentioned that although their center has a lot of experience with using imaging, they have not published much in this area yet. He highlighted the importance of using imaging to better understand the substrate for VT and how it can be used to guide ablation procedures. He discussed the work of Drs. Josephson and Wellens in identifying the subendocardial disease with fibrosis that can create the substrate for reentry at the subendocardial level. He talked about the challenges of mapping VT and the different approaches being used. He mentioned the use of mapping tools and imaging to help identify and target areas of electrophysiological vulnerability. He also discussed the use of high-density mapping and multiple-electrode systems in mapping scar tissue in VT patients. He touched on the use of CT and MRI imaging for scar detection and how it can be helpful in pre-planning and risk stratification for VT ablation procedures. He also mentioned the emerging software called "inheart" which can create detailed anatomical models from imaging data to aid in mapping and ablation procedures. Overall, the speaker emphasized the potential for imaging to improve the outcomes of VT ablation procedures by improving visualization, guidance, and targeting of scar tissue.
Keywords
imaging
ventricular tachycardia
ablation procedures
substrate for VT
mapping VT
electrophysiological vulnerability
high-density mapping
scar detection
inheart software
Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
2025
Privacy Policy
|
Cookie Declaration
|
Linking Policy
|
Patient Education Disclaimer
|
State Nonprofit Disclosures
|
FAQ
×
Please select your language
1
English